Overall, CSH1 promoted the expressions of immunosuppressive molecules represented by IL10 and PD-L1 and thus inhibited the cytotoxicity of effector T cells, leading to the progression of BLCA (Fig. 7O). The gene discussed is CSH1; the disease is bladder transitional cell carcinoma.